Relapse or Refractory Non-Hodgkin’s Lymphoma
Non-Hodgkin’s lymphoma (NHL) represents a diverse group of blood cancers originating in lymphatic tissues. While many patients respond positively to initial treatment regimens, some experience relapse or refractory forms of the disease. Relapse refers to the return of cancer after a period of remission, whereas refractory lymphoma indicates the disease’s resistance to treatment. These two